ClinicalTrials.gg
CompletedNCT05140538Updated May 12, 2022

A New Protocol for the Management of Dental Erosion in Rugby Players

An interventional study of SRP + toothpaste + mouthwash and SRP + toothpaste in Dental Erosion, sponsored by University of Pavia. Completed at 1 site in Italy. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-12.

Sponsored by University of Pavia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of the present study is to provide a new domiciliary oral care treatment for enamel remineralization in rugby players patients using mouthguards. Patients selected for the study will be randomly divided and allocated in two groups according to the treatment:

  • Group 1: scaling and root planing (SRP) + Biorepair Total Protective Repair toothpaste for home oral hygiene twice a day
  • Group 2: scaling and root planing (SRP) + Biorepair Total Protective Repair toothpaste + Biorepair mouthwash (3 in 1) for home oral hygiene twice a day

Patients will be given instructions for the cleaning of their mouthguards. The periodontal evaluation will be conducted before SRP, after 15, 30 and 90 days. The periodontal indices collected will be: PI, BoP, Schiff Air Index, BEWE index and dental sensitivity (VAS scale).

Read the detailed description

The aim of the present study is to provide a new domiciliary oral care treatment for enamel remineralization in rugby players patients using mouthguards and to prevent further worsening of dental erosion. Patients selected for the study will sign the informed consent and will be randomly divided and allocated into two groups:

  • Group 1: SRP + Biorepair Total Protective Repair toothpaste for home oral hygiene twice a day
  • Group 2: SRP + Biorepair Total Protective Repair toothpaste + Biorepair mouthwash (3 in 1) for home oral hygiene twice a day

Patients will be given instructions for the cleaning of their mouthguards. The periodontal evaluation will be conducted before SRP, after 15, 30 and 90 days. The periodontal indices collected will be: PI, BoP, Schiff Air Index, BEWE index and dental sensitivity (VAS scale).

02

Conditions studied

  • Dental Erosion

Browse trials for

Keywords

  • enamel remineralization
03

In context

Tooth Erosion

47 studies on the registry are indexed under Tooth Erosion; 7 are open to participants now.

This study's enrollment of 40 is above the median of 33 across 33 interventional studies indexed under Tooth Erosion.

Browse Tooth Erosion studies →

Lead sponsor

University of Pavia is the lead sponsor of 144 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients willing to participate to the study
  • Rugby players

Exclusion criteria

Exclusion Criteria:

  • Patients with cardiac pacemaker
  • Patients suffering from neurological disorders
  • Patients suffering from psychological disorders
  • Pregnant or breastfeeding women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Group 1

    SRP + Biorepair Total Protective Repair toothpaste for home oral hygiene twice a day

    Other: SRP + toothpaste

  • Experimental
    Group 2

    SRP + Biorepair Total Protective Repair toothpaste + Biorepair mouthwash (3 in 1) for home oral hygiene twice a day

    Other: SRP + toothpaste + mouthwash

Interventions

  • OtherSRP + toothpaste + mouthwash

    Use of domiciliary products twice a day

  • OtherSRP + toothpaste

    Use of domiciliary products twice a day

06

What researchers measure

Primary outcomes

  1. Change in BOP - Bleeding on Probing (percentage)

    Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 4 sites (mesial, distal, vestibular, palatal/lingual).

    Time frame: Study begin, 1 and 3 months

  2. Change in Schiff Air Index - Dental sensitivity test

    Scoring criteria: 0: the subject did not respond to air blasting; 1. the subject responded to air blasting; 2. the subject responded to air blasting and requested discontinuation; 3. the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.

    Time frame: Study begin and after 15, 30 and 90 days.

  3. Change of the BEWE Index - Basic Erosive Wear Examination (Barlet et al., 2008)

    Scoring criteria: 0: no erosive tooth wear; 1. initial loss of surface texture; 2. distinct defect, hard tissue loss \< 50% of the surface area; 3. hard tissue loss ≥ 50% of the surface area.

    Time frame: Study begin and after 15, 30 and 90 days.

  4. Change in PI - Plaque Index (percentage)

    Evaluation of the presence of plaque with a disclosing agent on the 4 surfaces of teeth on the total amount of dental surfaces multiplied per 100.

    Time frame: Study begin and after 15, 30 and 90 days.

  5. Dental sensitivity

    Assessment of dental sensitivity with a VAS scale (score: from 1 to 10)

    Time frame: Study begin and after 15, 30 and 90 days.

07

Study locations

1 site
  • Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
    Pavia, Lombardy 27100, Italy
08

References and documents

Individual participant data

Plan to share: No — Data will be available upon motivated request to Principal Investigator.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2021 to primary completion in Apr 2022, 4 months.

Of 20 interventional studies with no phase under Tooth Erosion, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 28. This study's 4 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2021
First posted
Dec 1, 2021
StartActual
Dec 18, 2021
Primary completionActual
Apr 27, 2022
CompletionActual
May 1, 2022
Last update
May 12, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05140538
Responsible party
Andrea Scribante (Research Resident, Principal Investigator, University of Pavia) — Principal investigator
First posted
Dec 1, 2021
Start date
Dec 18, 2021
Primary completion
Apr 27, 2022
Completion
May 1, 2022
Last update
May 12, 2022

Study contacts

Andrea Scribante, DDS, PhD
principal investigator · University of Pavia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion